Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Related articles

Pulmonary manifestations of systemic lupus erythematosus in adults

INTRODUCTION

At some time during their course, most patients with systemic lupus erythematosus (SLE) show signs of involvement of the lung, its vasculature, the pleura, and/or the diaphragm [1-5]. Pleurisy, coughing, and/or dyspnea are often the first clues either to lung involvement or to SLE itself [6]. In some cases, however, abnormal pulmonary function tests (PFTs), including the diffusing capacity for carbon monoxide (DLCO) and/or abnormal chest x-rays, may be detected in asymptomatic patients [7]. Pulmonary abnormalities do not correlate with complement levels, antinuclear antibody (ANA) levels, or other specific autoantibody levels such as anti-double-stranded DNA (dsDNA) and anti-Sm [8].

Patients with SLE and lung involvement must always be evaluated for infection, particularly that due to bacteria or viruses. Given that many are immunocompromised, tuberculosis, fungal infections, and other opportunistic infections should also be considered [9,10].

Overviews of the clinical manifestations of SLE in adults and children and a review of pulmonary disease in children with lupus are presented separately. (See "Overview of the clinical manifestations of systemic lupus erythematosus in adults" and "Systemic lupus erythematosus in children" and "Systemic lupus erythematosus in children: Pulmonary manifestations".)

PLEURITIC CHEST PAIN

Chest pain on breathing occurs in approximately 50 percent of patients with SLE [11,12]. It may be due to musculoskeletal causes or to pleuritis.

Musculoskeletal pain — In our experience, the most common cause of chest pain in systemic lupus erythematosus (SLE) is from muscles, connective tissues, or the costochondral joints (costochondritis or Tietze’s syndrome). The chest pain is characterized by painful deep breaths, aggravated by motion or by change of position (especially during sleep), and elicited by palpation of the painful areas. The patient can be reassured that this specific pain does not represent lung involvement. (See "Major causes of musculoskeletal chest pain in adults".)

                                

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jul 2014. | This topic last updated: Aug 26, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Rothfield NF. Cardiopulmonary manifestations. In: The Clinical Management of Systemic Lupus Erythematosus, Schur PH (Ed), Grune and Stratton, Orlando 1983.
  2. Orens JB, Martinez FJ, Lynch JP 3rd. Pleuropulmonary manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am 1994; 20:159.
  3. Pines A, Kaplinsky N, Olchovsky D, et al. Pleuro-pulmonary manifestations of systemic lupus erythematosus: clinical features of its subgroups. Prognostic and therapeutic implications. Chest 1985; 88:129.
  4. Keane MP, Lynch JP 3rd. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 2000; 55:159.
  5. Kim JS, Lee KS, Koh EM, et al. Thoracic involvement of systemic lupus erythematosus: clinical, pathologic, and radiologic findings. J Comput Assist Tomogr 2000; 24:9.
  6. Hellman DB, Kirsch CM, Whiting-O'Keefe Q, et al. Dyspnea in ambulatory patients with SLE: prevalence, severity, and correlation with incremental exercise testing. J Rheumatol 1995; 22:455.
  7. Nakano M, Hasegawa H, Takada T, et al. Pulmonary diffusion capacity in patients with systemic lupus erythematosus. Respirology 2002; 7:45.
  8. Silberstein SL, Barland P, Grayzel AI, Koerner SK. Pulmonary dysfunction in systemic lupus erythematosus:prevalence classification and correlation with other organ involvement. J Rheumatol 1980; 7:187.
  9. Kim HY, Im JG, Goo JM, et al. Pulmonary tuberculosis in patients with systematic lupus erythematosus. AJR Am J Roentgenol 1999; 173:1639.
  10. Rojas-Serrano J, Pedroza J, Regalado J, et al. High prevalence of infections in patients with systemic lupus erythematosus and pulmonary haemorrhage. Lupus 2008; 17:295.
  11. Pope J. An update in pulmonary hypertension in systemic lupus erythematosus - do we need to know about it? Lupus 2008; 17:274.
  12. Lawrence EC. Systemic lupus erythematosus and the lung. In: Systemic Lupus Erythematosus, Lahita RG (Ed), John Wiley and Sons, New York 1987.
  13. Turner-Stokes L, Turner-Warwick M. Intrathoracic manifestations of SLE. Clin Rheum Dis 1982; 8:229.
  14. Hunder GG, McDuffie FC, Hepper NG. Pleural fluid complement in systemic lupus erythematosus and rheumatoid arthritis. Ann Intern Med 1972; 76:357.
  15. Small P, Frank H, Kreisman H, Wolkove N. An immunological evaluation of pleural effusions in systemic lupus erythematosus. Ann Allergy 1982; 49:101.
  16. Sharma S, Smith R, Al-Hameed F. Fibrothorax and severe lung restriction secondary to lupus pleuritis and its successful treatment by pleurectomy. Can Respir J 2002; 9:335.
  17. Ginzler E, Diamond H, Kaplan D, et al. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum 1978; 21:37.
  18. Matthay RA, Schwarz MI, Petty TL, et al. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) 1975; 54:397.
  19. Wiedemann HP, Matthay RA. Pulmonary manifestations of systemic lupus erythematosus. J Thorac Imaging 1992; 7:1.
  20. Haupt HM, Moore GW, Hutchins GM. The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am J Med 1981; 71:791.
  21. Witt C, Dörner T, Hiepe F, et al. Diagnosis of alveolitis in interstitial lung manifestation in connective tissue diseases: importance of late inspiratory crackles, 67 gallium scan and bronchoalveolar lavage. Lupus 1996; 5:606.
  22. Weinrib L, Sharma OP, Quismorio FP Jr. A long-term study of interstitial lung disease in systemic lupus erythematosus. Semin Arthritis Rheum 1990; 20:48.
  23. Hedgpeth MT, Boulware DW. Interstitial pneumonitis in antinuclear antibody-negative systemic lupus erythematosus: a new clinical manifestation and possible association with anti-Ro (SS-A) antibodies. Arthritis Rheum 1988; 31:545.
  24. Wells AU, Hansell DM, Rubens MB, et al. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis. Am Rev Respir Dis 1993; 148:1076.
  25. Müller NL, Miller RR. Computed tomography of chronic diffuse infiltrative lung disease. Part 1. Am Rev Respir Dis 1990; 142:1206.
  26. Fenlon HM, Doran M, Sant SM, Breatnach E. High-resolution chest CT in systemic lupus erythematosus. AJR Am J Roentgenol 1996; 166:301.
  27. Bankier AA, Kiener HP, Wiesmayr MN, et al. Discrete lung involvement in systemic lupus erythematosus: CT assessment. Radiology 1995; 196:835.
  28. Tansey D, Wells AU, Colby TV, et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004; 44:585.
  29. Schattner A, Aviel-Ronen S, Mark EJ. Accelerated usual interstitial pneumonitis, anti-DNA antibodies and hypocomplementemia. J Intern Med 2003; 254:193.
  30. Gammon RB, Bridges TA, al-Nezir H, et al. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus. Chest 1992; 102:1171.
  31. Marenco JL, Sanchez-Burson J, Ruiz Campos J, et al. Pulmonary amyloidosis and unusual lung involvement in SLE. Clin Rheumatol 1994; 13:525.
  32. Swigris JJ, Olson AL, Fischer A, et al. Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease. Chest 2006; 130:30.
  33. Winslow TM, Ossipov MA, Fazio GP, et al. Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J 1995; 129:510.
  34. Prabu A, Patel K, Yee CS, et al. Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus. Rheumatology (Oxford) 2009; 48:1506.
  35. Quismorio FP Jr, Sharma O, Koss M, et al. Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin Arthritis Rheum 1984; 13:349.
  36. Rubin LA, Geran A, Rose TH, Cohen H. A fatal pulmonary complication of lupus in pregnancy. Arthritis Rheum 1995; 38:710.
  37. Roncoroni AJ, Alvarez C, Molinas F. Plexogenic arteriopathy associated with pulmonary vasculitis in systemic lupus erythematosus. Respiration 1992; 59:52.
  38. Steen V, Chou M, Shanmugam V, et al. Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis. Chest 2008; 134:146.
  39. Asherson RA, Oakley CM. Pulmonary hypertension and systemic lupus erythematosus. J Rheumatol 1986; 13:1.
  40. Yoshio T, Masuyama J, Sumiya M, et al. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1994; 21:2058.
  41. Asherson RA, Higenbottam TW, Dinh Xuan AT, et al. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 1990; 17:1292.
  42. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995; 333:214.
  43. Rubin LJ. Primary pulmonary hypertension. Chest 1993; 104:236.
  44. Palevsky HI, Fishman AP. The management of primary pulmonary hypertension. JAMA 1991; 265:1014.
  45. Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002; 346:896.
  46. Badesch DB, Hill NS, Burgess G, et al. Sildenafil for pulmonary arterial hypertension associated with connective tissue disease. J Rheumatol 2007; 34:2417.
  47. Cherin P, Brenot F, Bletry O, et al. Pulmonary hypertension in SLE: Hemodynamic effects of vasodilating agents. Lupus 1995; 4:171S.
  48. Gonzalez-Lopez L, Cardona-Muñoz EG, Celis A, et al. Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematosus. Lupus 2004; 13:105.
  49. Jais X, Launay D, Yaici A, et al. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum 2008; 58:521.
  50. Hennigan S, Channick RN, Silverman GJ. Rituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report. Lupus 2008; 17:754.
  51. Karim MY, Miranda LC, Tench CM, et al. Presentation and prognosis of the shrinking lung syndrome in systemic lupus erythematosus. Semin Arthritis Rheum 2002; 31:289.
  52. Laroche CM, Mulvey DA, Hawkins PN, et al. Diaphragm strength in the shrinking lung syndrome of systemic lupus erythematosus. Q J Med 1989; 71:429.
  53. Warrington KJ, Moder KG, Brutinel WM. The shrinking lungs syndrome in systemic lupus erythematosus. Mayo Clin Proc 2000; 75:467.
  54. Toya SP, Tzelepis GE. Association of the shrinking lung syndrome in systemic lupus erythematosus with pleurisy: a systematic review. Semin Arthritis Rheum 2009; 39:30.
  55. Rubin LA, Urowitz MB. Shrinking lung syndrome in SLE--a clinical pathologic study. J Rheumatol 1983; 10:973.
  56. Hardy K, Herry I, Attali V, et al. Bilateral phrenic paralysis in a patient with systemic lupus erythematosus. Chest 2001; 119:1274.
  57. Hawkins P, Davison AG, Dasgupta B, Moxham J. Diaphragm strength in acute systemic lupus erythematosus in a patient with paradoxical abdominal motion and reduced lung volumes. Thorax 2001; 56:329.
  58. Henderson LA, Loring SH, Gill RR, et al. Shrinking lung syndrome as a manifestation of pleuritis: a new model based on pulmonary physiological studies. J Rheumatol 2013; 40:273.
  59. Walz-Leblanc BA, Urowitz MB, Gladman DD, Hanly PJ. The "shrinking lungs syndrome" in systemic lupus erythematosus--improvement with corticosteroid therapy. J Rheumatol 1992; 19:1970.
  60. Soubrier M, Dubost JJ, Piette JC, et al. Shrinking lung syndrome in systemic lupus erythematosus. A report of three cases. Rev Rhum Engl Ed 1995; 62:395.
  61. Eagen JW, Memoli VA, Roberts JL, et al. Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) 1978; 57:545.
  62. Badsha H, Teh CL, Kong KO, et al. Pulmonary hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 2004; 33:414.
  63. Zamora MR, Warner ML, Tuder R, Schwarz MI. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 1997; 76:192.
  64. Hsu BY, Edwards DK 3rd, Trambert MA. Pulmonary hemorrhage complicating systemic lupus erythematosus: role of MR imaging in diagnosis. AJR Am J Roentgenol 1992; 158:519.
  65. Myers JL, Katzenstein AA. Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol 1986; 85:552.
  66. Schwab EP, Schumacher HR Jr, Freundlich B, Callegari PE. Pulmonary alveolar hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 1993; 23:8.
  67. Abud-Mendoza C, Diaz-Jouanen E, Alarcón-Segovia D. Fatal pulmonary hemorrhage in systemic lupus erythematosus. Occurrence without hemoptysis. J Rheumatol 1985; 12:558.
  68. Erickson RW, Franklin WA, Emlen W. Treatment of hemorrhagic lupus pneumonitis with plasmapheresis. Semin Arthritis Rheum 1994; 24:114.
  69. Godeau B, Cormier C, Menkes CJ. Bronchiolitis obliterans in systemic lupus erythematosus: beneficial effect of intravenous cyclophosphamide. Ann Rheum Dis 1991; 50:956.
  70. Abramson SB, Dobro J, Eberle MA, et al. Acute reversible hypoxemia in systemic lupus erythematosus. Ann Intern Med 1991; 114:941.
  71. Belmont HM, Buyon J, Giorno R, Abramson S. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited. Arthritis Rheum 1994; 37:376.
  72. Martinez-Taboada VM, Blanco R, Armona J, et al. Acute reversible hypoxemia in systemic lupus erythematosus: a new syndrome or an index of disease activity? Lupus 1995; 4:259.
  73. Montani D, Achouh L, Dorfmüller P, et al. Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine (Baltimore) 2008; 87:220.
  74. Kim WU, Kim SI, Yoo WH, et al. Adult respiratory distress syndrome in systemic lupus erythematosus: causes and prognostic factors: a single center, retrospective study. Lupus 1999; 8:552.
  75. Asherson RA, Cervera R. Review: antiphospholipid antibodies and the lung. J Rheumatol 1995; 22:62.
  76. Kanakis MA, Kapsimali V, Vaiopoulos AG, et al. The lung in the spectrum of antiphospholipid syndrome. Clin Exp Rheumatol 2013; 31:452.